SNOA

Conviction 45Scan · Mon, Aug 10, 2026

SNOA$1.30-10.07%

ResistanceSupportVol 14

Vol MA14 232.21K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Sonoma Pharmaceuticals, Inc.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.sonomapharma.com ↗

Price1.30

Change-10.07%

Gap-2.78%

Rel volume0.75×

Avg volume174.87K

Avg $ vol225.78K

SMA 201.19

SMA 501.18

SMA 2002.38

Price vs 50+9.96%

Price vs 200-45.57%

MA stackmixed

50/200 cross—

Supertrendup · 1.07

RSI (14)57

MACD hist0.02

MACD crossbull · 2d

Stoch %K / %D59 / 78

ADX (14)18

+DI / −DI25 / 10

RSI divergence—

MACD divergence—

ATR %+7.44%

ADR %6.40%

52w high5.35

52w low1.01

From 52w high-75.79%

Above 52w low+28.22%

New 52w highNo

SqueezeOff

Bollinger width25.87%

%B0.85

Donchian pos59.21%

Donchian high1.45

Donchian low1.07

AVWAP (52w high)4.69

vs AVWAP high-72.36%

AVWAP (52w low)1.14

vs AVWAP low+13.77%

OBV trendUp

Chaikin MF (20)0.31

Today vs 20d0.75×

Avg vol (14d)232.21K

Avg vol (20d)174.87K

Avg $ vol (20d)225.78K

Market cap—

RS 3m (vs SPY)+16.34%

RS 6m (vs SPY)-67.06%

RS line new highYes

Trend template2/8

Technical rank32.6

1 week+15.62%

1 month+2.78%

3 months+7.92%

6 months-57.26%

1 year-58.36%

YTD-64.42%

P/E-1.85

P/B0.89

P/S0.30

P/FCF-1.43

EPS-1.89

Div yield—

ROE-48.15%

ROA-17.53%

Debt/Eq0.09

Current2.99

EV/EBITDA-0.51

Gross margin37.97%

Net margin-16.26%

Rev growth36.68%

EPS growth8.16%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.16M

Revenue6.41M

Net income-330K

Gross profit2.58M

Free cash flow-4.13M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out3.47M

Employees168

ListedThu, Jan 25, 2007

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction45 / 100

Pattern quality—

Tech rank32.6 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.29

Support1.05

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNOA

All disclosures →

No recent disclosed trades by Congress in SNOA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNOA · 6 buys

Insider	Side	Shares	Value	Traded	Filed
DVONCH JEROME J Chief Financial Officer · Restricted Stock Units · 2026-07-09	Grant	10K	—	2026-07-09	2026-07-09
Dal Poggetto John Controller · Restricted Stock Units · 2026-07-09	Grant	7.5K	—	2026-07-09	2026-07-09
Jacoby Vanessa Director · Stock option (right to buy) · 2026-07-09	Grant	10K	—	2026-07-09	2026-07-09
MCLAUGHLIN JOHN Director · Stock option (right to buy) · 2026-07-09	Grant	10K	—	2026-07-09	2026-07-09
Trombly Amy Moss Chief Executive Officer · Restricted Stock Units · 2026-07-09	Grant	10K	—	2026-07-09	2026-07-09
Weigerstorfer Philippe Director · Stock option (right to buy) · 2026-07-09	Grant	10K	—	2026-07-09	2026-07-09

SEC filings

EDGAR filings in SNOA · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.